BIO ASIA 2013
Biotechnology being an emerging industry, game-changing strategies and relevant application of the knowledge-intelligence resource pool, drive the process of growth. BioAsia seeks to enhance, enrich and encourage newer innovations, path-breaking discoveries and effective solutions in the industry by offering a vibrant global platform for convergence of the key stakeholders - Biotech & Biopharma Companies, research institutions, investors, service providers, policy makers, regulators and analysts.
BioAsia is your Asian gateway in both directions (inward & outward) to explore the immense potential of Biotechnology. On a larger level, BioAsia partners with you to drive a global transformation from the treatment of illness to wellness. |
| Salient Features of BioAsia 2013 |
 |
Conference |
|
Tradeshow |
|
|
|
BioBazar- Pharmexcil’s International Buyer-Seller meet (BSM) during 28th to 30th January 2013. |
|
|
|
CEO Conclave |
|
Bio-Park Session |
|
| Who will attend? |
|
Leaders of the Biotechnology sector |
|
|
|
Prominent Importers/ Distributors & Traders North America, LAC, CIS, Africa & ASEAN regions. |
|
|
|
Scientific & Medical device manufacturers & Suppliers |
|
|
|
Key government decision makers |
|
|
|
FDA/Drug Registration/ MoH officials from overseas and India. |
|
Press/ Media |
|
| Products Covered: |
|
Bio-generics (Biosimilar) |
|
Vaccines |
|
Anti biotics |
|
Diagnostics |
|
Oncology drugs |
|
Monoclonal Antibodies |
|
Veterinary Biologicals |
|
Insulin |
|
Statins |
|
Medical Devices and Surgicals. |
|
Bio Services (Clinical Research/CRO’s) |
|
